SHINE will have several representatives at the 2022 Mo-99 International Symposium in Vienna, Austria. Founder and CEO Greg Piefer will update attendees about SHINE’s progress toward producing molybendum-99 at The Chrysalis in Janesville, Wisconsin. The event, which is hosted by the U.S. Department of Energy’s National Nuclear Security Administration, will also include presentations from other global and North American Mo-99 producers, technology development updates, supply chain perspectives and more.
BioForward Wisconsin’s annual Biohealth Summit is Oct. 12 in Madison. It focuses on celebrating successes and collaboration within Wisconsin’s biohealth community. SHINE General Manager of Therapeutics Chris Vessel will participate in a panel discussion on “Therapies and Theranostics in Medical Imaging.” He will shed more light on how our medical isotope production will have a profound effect in diagnosing and treating millions of patients around the world.
You will find SHINE in Booth #63 at EANM ’22 – the 35th Annual Congress of the European Association of Nuclear Medicine – in Barcelona, Spain. About 7,000 attendees and 180 companies will get together to discuss the newest trends and findings within the nuclear medicine industry.
Heading to EANM? Let us know! Or stop by and see us in our booth.
